Physician profile
John Fang
NPI 1134219736
$11,769.84
in general payments reported to CMS, 2019-2025
14 companies · $1,270 in 2025
The $1,270 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $4,927 · 2022: $1,244 · 2023: $3,346 · 2024: $721 · 2025: $1,270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,765 · Food and Beverage: $1,343 · Travel and Lodging: $1,197 · Education: $31.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,765.00 |
| Food and Beverage | $1,343.36 |
| Travel and Lodging | $1,197.47 |
| Education | $31.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $3,770.00 | 2020 | |
| Merit Medical Systems INC | $3,037.50 | 2020-2023 | |
| Boston Scientific Corporation | $2,697.56 | 2022-2025 | Overstitch Nxt Endoscopic Suturing System, General - Therapies, Orise |
| Fujifilm Healthcare Americas Corporation | $938.32 | 2025 | |
| Circa Scientific, INC. | $800.00 | 2023 | |
| Romark Laboratories, Lc | $199.65 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $188.95 | 2019-2024 | Entyvio |
| Erbe USA INC | $35.00 | 2020 | |
| Pfizer INC. | $31.00 | 2025 | |
| Phathom Pharmaceuticals, INC. | $28.23 | 2025 | Voquezna |
| Avanos Medical | $24.58 | 2019 | |
| Medtronic, INC. | $19.05 | 2024 | Manoscan |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Fang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.